Previous Close | 13.41 |
Open | 12.80 |
Bid | 13.34 x 0 |
Ask | 13.35 x 0 |
Day's Range | 13.29 - 13.50 |
52 Week Range | 9.05 - 16.57 |
Volume | |
Avg. Volume | 7,713,345 |
Market Cap | 2.76B |
Beta (5Y Monthly) | 0.49 |
PE Ratio (TTM) | 19.36 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 0.11 (0.82%) |
Ex-Dividend Date | Jul 04, 2023 |
1y Target Est | N/A |
Insights into Geron Corp's robust financial standing and strategic updates, including FDA discussions and trial timelines.
Geron (GERN) delivered earnings and revenue surprises of 10% and 102.67%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?